SR Medical Technology Company Limited

HK$2.29As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0108Real Estate
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 9.25%
Div yield —
ROE (8.27%)
Real Estate Services
Beta (5Y) (1.42)
PE TTM —
TSR TTM 15.91%
Mkt cap HK$7.623B
ROIC 0.32%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.39
4.01%
(69.60%)
Hold 8|10|3|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
12.50%
14.12%
16.17%
6.64%
Revenue$M
720.0
723.5
706.9
714.1
0.38%
3.90%
(0.27%)
0.44%
Peers (US$972.3M)
Cap (US$)
PE
1.372B
9.155x
Capital
TTM
5Y
10Y
Leveragex
1.214
(4.221)
(3.584)
EBIT/Intx
1.145
0.681
0.573
Own earn%
(26.95)
55.18
31.26
Sh yield%
34.95
37.39
37.06
Owners
Insiders/Inst%
11.02
57.13
Short interest%
0.55
SBC / revenue%
1.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
10–17
$1 testx
−0.1
Incr. ROIC%
5